In 2024, over 20 million people in the UK waited more than a month just to see a GP. At the same time, brands like Clue and Lovehoney have huge, loyal audiences, but can’t offer regulated healthcare (yet). Patients want pharmacy care to be as easy as online banking, but regulators still demand full clinical compliance.
That’s where Evaro steps in: their NHS, CQC, and GPhC-licensed healthcare-as-a-service platform lets brands embed everything from consultations to prescriptions and aftercare right inside their apps.
Fresh off a $25M Series A led by AlbionVC, with Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI joining in, Evaro has already helped two million patients get care where they need it.
Bringing healthcare to where patients already are
Founded in 2018 by emergency physician Dr Thuria Wenbar (CEO) and pharmacist-researcher Dr Oskar Wenbar (CMO), Evaro was born out of frustration with growing NHS wait times. Both saw firsthand how patients suffered from routine conditions that could be treated more quickly.
Evaro’s API-first platform can be up and running in just two weeks, offering a full clinical stack: asynchronous consultations, NHS GP record access, remote diagnostics, automated dispensing, and aftercare. They already support 80+ conditions and have a 4.5 Trustpilot rating.
Key differentiators include seamless patient experience within partner apps such as Clue and Lovehoney, simultaneous CQC, GPhC, and NHS licensing (seven approvals), enabling legal brand healthcare, and a comprehensive service offering that extends beyond diagnosis to include consultation, pharmacy, and aftercare.
While Babylon, Push Doctor, and Pharmacy2U are in the mix, none of them offer white-label healthcare-as-a-service for consumer brands like Evaro does.
What’s next?
With this new funding, Evaro is set to expand beyond women’s and men’s health into longevity and advanced diagnostics, partner with more brands, healthcare orgs, and employer benefits programs, and keep evolving their API for even smoother integration.
